Shelley L. Berger,Xianxin Hua,Morgan Sammons,Jiajun Zhu
申请号：
US15110967
公开号：
US20160339035A1
申请日:
2015.01.14
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention provides compositions and methods for treating and preventing cancer. The invention comprises an inhibitor of epigenetic regulators, including MLL1, MLL2, MOZ, menin, WDR5, or a combination thereof. In one embodiment, the invention provides a personalized method of treating a cancer as dependent upon its epigenetic signature.
